Health

HAVAS HEALTH & YOU BOLSTERS OFFERINGS IN APAC WITH KEY EXPANSIONS, PROMOTIONS ACROSS REGION

NEW YORK, April 5, 2023 /PRNewswire/ -- APAC's healthcare sector has evolved rapidly in recent years, necessitating a groundswell of growth and investment. To help global brands thrive in this changing climate and support them as they expand, Havas Health & You (HH&Y), the world's largest global ...

2023-04-05 05:00 1768

Standigm and Institut Pasteur Korea Identify Lead Compounds for Resistant Tuberculosis Thanks to Right Foundation Grant

Research achievements enabled by a combination of advanced AI platforms, research capabilities, and drug discovery technologies SEOUL, South Korea, April 4, 2023 /PRNewswire/ -- Standigm , a company using artificial intelligence (AI) technology for drug discov...

2023-04-05 00:07 2174

DSM AND FIRMENICH HAVE OBTAINED ALL COMPETITION CLEARANCES

ACCEPTANCE PERIOD ENDS ON 17 APRIL 2023 AT 17:40 CEST THIS PRESS RELEASE IS NOT FOR GENERAL RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, IN OR INTO, DIRECTLY OR INDIRECTLY,THE UNITED STATES OR ANY OTHER JURISDICTION WHERE SUCH RELEASE, PUBLICATION OR DISTRIBUTION WOULD VIOLATE APPL...

2023-04-04 21:32 2590

Goodwin Biotechnology Inc. (GBI) Announces First Commercial Contract Signing

PLANTATION, Fla., April 4, 2023 /PRNewswire/ -- GBI proudly announces the signing of their first Master Supply Agreement for commercializing an antibody. With the development of this new partnership, GBI's integrated CDMO biologics services will showcase their expertise in bringing a product from...

2023-04-04 20:57 2072

Biosion Initiates Phase II Clinical Trial of BSI-045B in Atopic Dermatitis

NEWARK, Del. and NANJING, China, April 4, 2023 /PRNewswire/ -- Biosion USA, Inc. (Biosion), a global clinical-stage R&D biotechnology company, today announced that it has successfully opened an IND following review by the U.S. Food and Drug Administration toinitiate a Phase 2 clinical trial of BS...

2023-04-04 20:50 1710

Metabolon Launches Bile Acids and Short Chain Fatty Acids Targeted Panels to Advance Understanding of Microbiome and Gut Metabolome in Health and Disease

Targeted metabolomics panels provide absolute quantitation for important bioactive intermediaries of the microbiome and gastrointestinal gut health MORRISVILLE, N.C., April 4, 2023 /PRNewswire/ -- Metabolon, Inc., the global leader in providing metabolomics solutions that advance a wide variety o...

2023-04-04 20:03 1775

Lynk Pharmaceuticals Announces Positive Results for LNK01003 in Phase I Trial in Healthy Subjects

HANGZHOU, China, April 4, 2023 /PRNewswire/ -- Lynk Pharmaceuticals Co., Ltd. (hereinafter referred to as 'Lynk Pharmaceuticals'), an innovative clinical stage company, announced that it has recently completed phase I trials in healthy subjects inChina for its self-developed innovative intestina...

2023-04-04 20:00 2687

Latest Updates of 6 Viva's Portfolio Companies

HONG KONG, April 4, 2023 /PRNewswire/ -- Even with the ever-changing situation, technological innovation is still the most critical component for biopharmaceutical companies' long-term development. This continuous innovation keeps companies up to date and promotes the evolution of R&D and the suc...

2023-04-04 19:39 2227

Cambrex Opens New Stability Storage Facility in Belgium

EAST RUTHERFORD, N.J., April 4, 2023 /PRNewswire/ -- Cambrex, a leading global contract development and manufacturing organization (CDMO) providing drug substance, drug product, and analytical services across the entire drug lifecycle, today announced that their stability storage business, Q1 Sc...

2023-04-04 15:00 1864

iNtRON confirms cancer-controlling effect of PHAGERIA® drug candidate in the organoid model.

* Secured the effectiveness confirming data of PHAGERIA® technology for colorectal cancer organoids * The first target cancer type of PHAGERIA® technology is colorectal cancer (CRC) BOSTON and SEOUL, South Korea, April 3, 2023 /PRNewswire/ -- iNtRON Biotechnology ("iNtRON",www.intodeworld.com...

2023-04-04 10:33 1978

Bridgewest Group completes acquisition of sterile injectable manufacturing plant in Western Australia from Pfizer

MIAMI and PERTH, Australia, April 4, 2023 /PRNewswire/ -- Global private investment firm,Bridgewest Group, recognized for developing innovative companies in life sciences, software, and deep tech, announces that it has completed the acquisition of thePerth sterile injectable manufacturing facilit...

2023-04-04 10:00 2643

BioDuro-Sundia Wins Life Sciences Review Top 10 BPO Award

IRVINE, Calif., April 4, 2023 /PRNewswire/ -- Life Sciences Review magazine recognizes BioDuro-Sundia as top 10 Business Process Outsourcing (BPO). BioDuro-Sundia earned this award for its high-quality service and cutting-edge technology, as well as its integrated contract research, development a...

2023-04-04 08:30 2358

Lynk Pharmaceuticals Announces Positive Results for LNK01003 in Phase I Trial in Healthy Subjects

HANGZHOU, China, April 4, 2023 /PRNewswire/ -- Lynk Pharmaceuticals Co., Ltd. (hereinafter referred to as 'Lynk Pharmaceuticals'), an innovative clinical stage company, announced that it has recently completed phase I trials in healthy subjects inChina for its self-developed innovative intestina...

2023-04-04 08:00 2489

AnPac Bio-Medical Science Enters into Asset Purchase Agreement with Easy Hundred Inc.

NEW YORK, April 3, 2023 /PRNewswire/ -- AnPac Bio-Medical Science Co., Ltd. (the "Company") (NASDAQ: ANPC), a company with operations inthe United States andChina focused on early cancer screening and detection and entering into the operation of a business-to-business e-commerce food platform foc...

2023-04-03 21:00 2630

GC Cell and New Management Embarking on a New Chapter

* Securing future growth engine by scouting global talents; AGM resolved new CEOJames Park and CTO Ho-won Kim as internal directors * Setting business goals focusing on change and growth * Proposing a new corporate vision of "Global Creator of Cell & Gene Therapy" YONGIN,South Korea, April 3...

2023-04-03 16:47 2027

Timekettle AI Translator Earbuds Empower International Medical Workers

SHENZHEN, China, April 3, 2023 /PRNewswire/ -- Technology company, Timekettle, recently sponsored the 13th Global Implantology Week organized by the ZimVie Association atNew York University. The four-day event brought together medical experts from over 30 countries to share their knowledge and ex...

2023-04-03 16:17 1525

Harbour BioMed Reports Full Year 2022 Financial Results

CAMBRIDGE, Mass., SUZHOU, China and ROTTERDAM, Netherlands, April 3, 2023 /PRNewswire/ -- Harbour BioMed ("HBM" or the "Company"; HKEX: 02142), a global biopharmaceutical company committed to the discovery, development and commercialization of novel antibody therapeutics focusing on immune-oncolo...

2023-04-03 15:10 3380

Perisai Paves the Way in Asia - Introducing Voice and Behavioral Risk Assessment for Insurance and Health Sectors.

SINGAPORE, April 3, 2023 /PRNewswire/ -- Voicesense and Bizbaz announce a new joint product called Perisai—Malay forShield. Specifically designed for insurance, reinsurance, health and wellness companies, Perisai builds on the partners' existing cooperation in finance, e-commerce, mental health a...

2023-04-03 15:00 8130

The World's Second Approved Biosimilars of Denosumab (MAILISHU)

SHANGHAI, April 3, 2023 /PRNewswire/ -- Mabwell (688062.SH), an innovative biopharmaceutical company with the layout of whole industry chain, announced that the Denosumab solution for injection (trade name: MAILISHU, project code: 9MW0311), which is developed by its wholly-owned subsidiary T-m...

2023-04-03 13:44 1752

Tiens Group Attends Boao Forum for Asia Annual Conference 2023

Tiens focuses on global markets by engaging with likeminded peers from the four corners of the globe BOAO, China, April 3, 2023 /PRNewswire/ -- The highly anticipated Boao Forum forAsia (BFA) Annual Conference 2023 themed "An Uncertain World: Solidarity and Cooperation for Development amid Chall...

2023-04-03 10:39 2593
1 ... 179180181182183184185 ... 820